Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
4,191
archived clinical trials in
Constipation

A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 270
773
mi
from 43215
Mandeville, LA
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 270
773
mi
from 43215
Mandeville, LA
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 214
802
mi
from 43215
Marrero, LA
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 214
802
mi
from 43215
Marrero, LA
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 188
795
mi
from 43215
Metairie, LA
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 188
795
mi
from 43215
Metairie, LA
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 432
787
mi
from 43215
Shreveport, LA
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 432
787
mi
from 43215
Shreveport, LA
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 271
798
mi
from 43215
Bangor, ME
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 271
798
mi
from 43215
Bangor, ME
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 160
354
mi
from 43215
Annapolis, MD
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 160
354
mi
from 43215
Annapolis, MD
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 255
341
mi
from 43215
Towson, MD
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 255
341
mi
from 43215
Towson, MD
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 267
643
mi
from 43215
Brockton, MA
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 267
643
mi
from 43215
Brockton, MA
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 260
164
mi
from 43215
Ann Arbor, MI
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 260
164
mi
from 43215
Ann Arbor, MI
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 283
341
mi
from 43215
Buckley, MI
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 283
341
mi
from 43215
Buckley, MI
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 239
213
mi
from 43215
Flint, MI
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 239
213
mi
from 43215
Flint, MI
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 168
303
mi
from 43215
Troy, MI
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 168
303
mi
from 43215
Troy, MI
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 216
246
mi
from 43215
Wyoming, MI
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 216
246
mi
from 43215
Wyoming, MI
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 221
738
mi
from 43215
Biloxi, MS
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 221
738
mi
from 43215
Biloxi, MS
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 282
498
mi
from 43215
Jefferson City, MO
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 282
498
mi
from 43215
Jefferson City, MO
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 156
1348
mi
from 43215
Billings, MT
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 156
1348
mi
from 43215
Billings, MT
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 275
1761
mi
from 43215
Las Vegas, NV
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 275
1761
mi
from 43215
Las Vegas, NV
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 175
426
mi
from 43215
Vineland, NJ
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 175
426
mi
from 43215
Vineland, NJ
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 293
1329
mi
from 43215
Albuquerque, NM
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 293
1329
mi
from 43215
Albuquerque, NM
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 151
280
mi
from 43215
Brooklyn, NY
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 151
280
mi
from 43215
Brooklyn, NY
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 170
491
mi
from 43215
Great Neck, NY
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 170
491
mi
from 43215
Great Neck, NY
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 203
494
mi
from 43215
New Hyde Park, NY
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 203
494
mi
from 43215
New Hyde Park, NY
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 205
408
mi
from 43215
Fayetteville, NC
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 205
408
mi
from 43215
Fayetteville, NC
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 104
321
mi
from 43215
Greensboro, NC
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 104
321
mi
from 43215
Greensboro, NC
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 194
306
mi
from 43215
Hickory, NC
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 194
306
mi
from 43215
Hickory, NC
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 412
485
mi
from 43215
Wilmington, NC
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 412
485
mi
from 43215
Wilmington, NC
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 172
57
mi
from 43215
Beavercreek, OH
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 172
57
mi
from 43215
Beavercreek, OH
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 223
94
mi
from 43215
Cincinnati, OH
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 223
94
mi
from 43215
Cincinnati, OH
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 173
63
mi
from 43215
Dayton, OH
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 173
63
mi
from 43215
Dayton, OH
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 208
73
mi
from 43215
Franklin, OH
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 208
73
mi
from 43215
Franklin, OH
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 171
58
mi
from 43215
Huber Heights, OH
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 171
58
mi
from 43215
Huber Heights, OH
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 219
77
mi
from 43215
Lima, OH
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 219
77
mi
from 43215
Lima, OH
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 232
99
mi
from 43215
Wadsworth, OH
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 232
99
mi
from 43215
Wadsworth, OH
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 236
849
mi
from 43215
Oklahoma City, OK
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 236
849
mi
from 43215
Oklahoma City, OK
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 273
751
mi
from 43215
Tulsa, OK
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 273
751
mi
from 43215
Tulsa, OK
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 220
430
mi
from 43215
Levittown, PA
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 220
430
mi
from 43215
Levittown, PA
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 248
621
mi
from 43215
East Providence, RI
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 248
621
mi
from 43215
East Providence, RI
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 404
426
mi
from 43215
Columbia, SC
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 404
426
mi
from 43215
Columbia, SC
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 265
346
mi
from 43215
Gaffney, SC
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 265
346
mi
from 43215
Gaffney, SC
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 246
1072
mi
from 43215
Rapid City, SD
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 246
1072
mi
from 43215
Rapid City, SD
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 261
744
mi
from 43215
Sioux Falls, SD
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 261
744
mi
from 43215
Sioux Falls, SD
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 134
359
mi
from 43215
Chattanooga, TN
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 134
359
mi
from 43215
Chattanooga, TN
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 121
348
mi
from 43215
Franklin, TN
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 121
348
mi
from 43215
Franklin, TN
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 189
326
mi
from 43215
Hermitage, TN
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 189
326
mi
from 43215
Hermitage, TN
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 133
436
mi
from 43215
Jackson, TN
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 133
436
mi
from 43215
Jackson, TN
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 109
283
mi
from 43215
Knoxville, TN
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 109
283
mi
from 43215
Knoxville, TN
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 266
508
mi
from 43215
Memphis, TN
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 266
508
mi
from 43215
Memphis, TN
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 235
335
mi
from 43215
Nashville, TN
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 235
335
mi
from 43215
Nashville, TN
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 279
279
mi
from 43215
Spring Hill, TN
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 279
279
mi
from 43215
Spring Hill, TN
Click here to add this to my saved trials
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated:  12/31/1969
Ardelyx Investigative Site 180
980
mi
from 43215
Channelview, TX
A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
Status: Enrolling
Updated: 12/31/1969
Ardelyx Investigative Site 180
980
mi
from 43215
Channelview, TX
Click here to add this to my saved trials